Results 101 to 110 of about 68,882 (316)

Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy [PDF]

open access: yes, 2006
Aims: While the downstream effects of increased reactive oxygen species (ROS) in the pathogenesis of diabetes were well studied, only a few studies have explored the cellular sources of ROS.
Adaikalakoteswari, A   +3 more
core   +1 more source

Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up [PDF]

open access: yes, 2015
The aim was to evaluate circulating levels of reactive oxygen species (ROS) and changes in central macular thickness (CMT) in patients with nonproliferative diabetic retinopathy (NPDR) after antioxidant supplementation.
Carnevale, Carmela   +5 more
core   +4 more sources

Complement-mediated thrombotic microangiopathy associated with lupus nephritis.

open access: yesBlood Advances, 2018
Complement-mediated thrombotic microangiopathy (CM-TMA) is a clinical disorder driven by the generation of excess complement. It is characterized by thrombocytopenia and microangiopathic hemolytic anemia (MAHA) with microvascular thrombosis resulting in ...
Mi-Hee Park   +3 more
semanticscholar   +1 more source

Blood glucose screening in dental clinics as an opportunity for detection of diabetes and prediabetes: The Kyoutou Dental and Diabetes (KDD) Study

open access: yesJournal of Diabetes Investigation, EarlyView.
ROC curves for positive blood glucose screening. Model 1 (blue) included age, sex, history of diabetes, and smoking history. Model 2 (green) includes the PPD, BOP rate, and BL. Model 3 (red) included items from Models 1 and 2. ABSTRACT Aims/Introduction This study aimed to determine the prevalence and characteristics of positive blood glucose screening
Nozomi Harai   +19 more
wiley   +1 more source

Thrombotic thrombocytopenic purpura as a rare cause of anemia with thrombocytopenia in childhood: report of 2 cases

open access: yesThe Turkish Journal of Pediatrics, 2019
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disorder characterized by single or recurrent episodes of thrombocytopenia, microangiopathic hemolytic anemia and widespread microvascular thrombosis, which causes significant morbidity and
Oya Köker   +3 more
doaj   +1 more source

Serum cystatin C and chemerin levels in diabetic retinopathy [PDF]

open access: yes, 2017
Peer reviewedPublisher ...
Chen, Xuedong   +5 more
core  

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study [PDF]

open access: yes, 2018
Introduction: DPP-4 inhibitors (DPP4i) and sulfonylureas are popular second-line therapies for type 2 diabetes (T2D), but there is a paucity of real-world studies comparing their effectiveness in routine clinical practice. Methods: This was a multicenter
Avogaro Angelo   +10 more
core   +1 more source

Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds

open access: yesNeurology, 2019
Objective To test the hypothesis that patients with concomitant lobar and deep intracerebral hemorrhages/microbleeds (mixed ICH) have predominantly hypertensive small vessel disease (HTN-SVD) rather than cerebral amyloid angiopathy (CAA), using in vivo ...
Hsin-Hsi Tsai   +10 more
semanticscholar   +1 more source

Cancer and Thrombotic Microangiopathy [PDF]

open access: yesJournal of Oncology Practice, 2016
Cancer-Associated Thrombotic Microangiopathy Thrombotic microangiopathy (TMA) is a general term that describes the clinical features of thrombocytopenia and microangiopathic hemolytic anemia, in conjunction with a raised lactate dehydrogenase level, reticulocytosis, and often hyperbilirubinemia.
openaire   +3 more sources

Ocular Neuromyotonia—A Rare but Reversible Cause of Intermittent Diplopia

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Parthvi Ravat   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy